Intrinsic Value
Recro Pharma, Inc. (REPH)
$2.09
-0.01 (-0.48%)
| Enterprise Value | -16.62 |
|---|---|
| Net Debt | 33.92 |
| Equity Value | -50.54 |
| Shares Outstanding | 95,229.19 |
| Equity Value Per Share | -0.00 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt